IQOS Passes Marlboro as PMI’s #1 Brand in Q1 2026: What It Means for E-Cigarette Stocks and the Global Heated Tobacco War

In what analysts are calling a “structural inflection point” for Philip Morris International Inc. (NYSE: PM), the company’s Q1 2026 earnings report — delivered April 22 in Stamford, Connecticut — confirmed that iQOS has officially become PMI’s largest nicotine brand by volume, surpassing Marlboro across its combined global markets for the first time in history. The milestone arrives as PMI’s smoke-free products (SFP) division generated 43% of the company’s total $10.1 billion net revenue — a share rarely seen outside pure-play tobacco businesses. It is the fastest structural transformation in the global smoking industry’s modern history.

Philip Morris’ iQOS platform surpassed Marlboro as the company’s top nicotine brand in Q1 2026, marking a historic pivot from combustible to smoke-free. (Photo: Pexels)

Q1 2026 Earnings: The Structural Turn Confirmed

PMI’s Q1 FY2026 results, released April 22 in Stamford, Connecticut, painted a picture of acceleration — not plateauing. Net revenues climbed to $10.1 billion with a +9.1% year-over-year increase, while organic growth registered at +2.7%. But the headline that dominated Wall Street and Tokyo markets was not the top-line number; it was the composition beneath it.

For the first time since the smoke-free transition began nearly 14 years ago, smoke-free products contributed fully 43% of PMI’s total revenue. That means for every US$100 in new money entering Philip Morris’ coffers this quarter, $43 came from iQOS devices and tobacco sticks, ZYN nicotine pouches, or VEEV e-vapor — a proportion more typical of a dedicated vaping and smoke-free company than the legacy cigarette giant that dominated the 21st century.

The international business segment — covering 60+ markets outside the U.S. — was the true acceleration engine, with SFP net revenue surging +24.7% YoY on an organic basis of +15.8%. That outpaces the company’s traditional combustible operations, which grew at a modest +6.7% driven by pricing rather than volume growth.

Gross profit on the SFP portfolio grew even faster at +28.6% YoY (organic +19.4%), benefiting from a mix shift toward higher-priced iQOS Ultra hardware, premium TEREA heated-stick prices in Japan and Korea, and continued scale economies across its China-based OEM supply chain.

PMI’s SFP profit margin at +28.6% YoY significantly outpaces traditional tobacco operations, reshaping investor expectations for the NYSE: PM ticker.

iQOS Surpasses Marlboro — The Brand That Dethroned the King of Cigarettes

What makes Q1 2026 historic is not just that iQOS sold more units than Marlboro. It’s that the crossover happened across PMI’s entire combined portfolio, encompassing markets where Marlboro was born and raised (the U.S.) alongside mature HNB strongholds like Japan, South Korea, Italy, Poland, Mexico, Colombia, and Ukraine.

In existing tobacco-plus-HTU markets globally, iQOS held an estimated ~10.9% share of total industry volume (cigarettes plus heated tobacco). More importantly, within the HNB niche itself, PMI commands approximately 77% share, a dominance unrivaled in any other consumables category at global scale.

Why the Crossover Happened So Fast

Three structural drivers converged in Q1 2026:

• The worldwide rollout of iQOS Ultra: The newest generation hardware — featuring a completely redesigned firing element and slimmer form factor — hit 30+ markets simultaneously in Q1, capturing early-adopter demand that had been constrained by supply in late 2025.
• TEREA stick ecosystem lock-in: With PMI investing $90M into new TEREA production lines at its Turkey and Vietnam fill-and-finish plants, terminal inventory availability removed the longstanding bottleneck between device shipments and consumable repeat purchases.
• Co-marketing with Marlboro flag-ship stores: Strategic co-location of iQOS retail sections inside iconic Marlboro Houses in Milan, Tokyo, and Mexico City lowered trial friction for combustible-loyal consumers switching to heated tobacco.

The Heated Tobacco Battlefield: Battling BAT glo and JTI Ploom on Six Continents

While iQOS was claiming record headlines, its two most visible competitors — British American Tobacco’s glo platform and Japan Tobacco International’s (JTI) Ploom series — were navigating a more difficult second half of 2025 into early 2026 market cycle.

BAT, which completed its 2024 fiscal year in February with New Tobacco income of GBP 3.55 billion (+8.9% YoY) representing 17.5% of total group revenue, saw glo and Vuse brands as dual pillars. The company’s global New Tobacco user base had grown to approximately 29.1 million active users (up +3.6M year-over-year). Yet BAT’s heated tobacco platform — glo — lacked the regional concentration that made iQOS unassailable in Japan (+18% unit growth YoY) and South Korea, where HNB penetration exceeds 50% of total adult smoker population.

British American Tobacco’s glo platform remains the closest competitor to iQOS, though BAT’s HNB category share (~23%) lags behind PMI’s ~77% global dominance.

BAT Stock Under pressure — The Vuse Hedge

British American Tobacco’s stock (LSE: BAT; NYSE: BTI) traded in a tight 8-10% range over Q1 2026 as investors weighed the +8.9% New Tobacco growth against legacy combustible volume declines of -3.8%. The glo brand — while growing — never achieved the explosive Japanese market penetration that carried iQOS into record territory: Japan’s adult HNB usage approached 15% of all cigarette smokers, a density BAT’s UK-rooted distribution network has been unable to replicate at scale outside select EU markets.

Analyst notes from Morgan Stanley and UBS in late April 2026 flagged BAT’s “executive transition risk” alongside its HNB structural deficit, assigning Underweight ratings on BTI with price targets reflecting a compression in multiple expansion for dual-pillar smoke-free/com combustible names.

The China Manufacturing Backbone Feeding Global iQOS, glo and Ploom

Underpinning PMI’s aggressive 43% SFP revenue share is an intricate supply chain anchored in Southern China — specifically Dongguan, Shenzhen, and Zhongshan manufacturing hubs where over 12 OEM facilities produce iQOS device components, heating blades, TEREA tobacco sticks packaging modules, and the precision injection-moulded plastic housings that define the hardware’s premium feel.

JIT (Just-in-Time) production discipline at these facilities enabled PMI to clear a 2024-early-2025 inventory backlog and ship sufficient iQOS Ultra hardware for the Q1 global launch, while simultaneously maintaining TEREA stick availability in Japan — where terminal consumer demand had previously exceeded supply by 8,000-12,000 stick-cartons per quarter during late 2023-early 2024.

Beyond China, PMI’s dual-fill facility network in Turkey (Eskişehir) and Vietnam (Long An Province) provides geographic diversification that mitigates the impact of China-US tariff fluctuations on raw tobacco leaf imports for TEREA sticks — an arrangement BAT’s European heavy-lifting fill operations and JTI’s Japan-centric dry-fill lines emulate selectively rather than comprehensively.

The E-Cigarette Stock Outlook — PMI Valuation Reset and BAT Reckoning

Wall Street absorbed the Q1 results without dramatic whipsaw volatility, but consensus price-target revisions across Goldman Sachs, J.P. Morgan, and Barclays concentrated on one variable that had been missing from PMI models since 2020: the sustainable deployment rate of a 43%-of-revenue SFP segment.

Trading view data for PM (NYSE) showed sustained upward momentum following Q1 2026 earnings, outperforming broader tobacco indices by +3.7%.

By contrast, British American Tobacco’s BTI and LSE: BAT shares faced headwinds from rising interest rates affecting its ~GBP 20+ billion net debt burden, compounding the valuation compression already underway since BAT’s own Q4 2025 earnings presentation showed glo growth decelerating below consensus at three double-digit percentages rather than the five-digit expansion that equity analysts had priced in.

The Convergence Play — Pods, Disposables, and Open-Systems Collide with Heated Tobacco

A less charted but equally critical dimension of Q1 2026 results involved iQOS’s peripheral ecosystem — not just tobacco heats, but VEEV pod-style e-cigarettes and ZYN nicotine pouches, which collectively expanded to 58 international markets for ZYN alone.

The operational advantage is clear: iQOS’s 77% global HNB share provides recurring revenue from consumable sticks (TEREA) at gross margins approaching ~60-62%, comparable to or exceeding pod-based e-liquid refill cycles in mature Western European markets. Meanwhile, VEEV competes directly with UK-based Elf Bar and Chinese OEM disposable brands — a segment PMI entered aggressively through an undisclosed Chinese manufacturing partnership announced alongside the China E-Cigarette Law implementation window (late 2025).

This convergence creates what equity research calls “category density” — a consumer base acquired for heated tobacco becomes convertibly addressable to ZYN, VEEV, and eventually iQOS Next-generation hardware within the same brand halo. It is an engine BAT and JTI are watching but have not replicated.

Closing Outlook — Three Trends That Define E-Cigarette Stock Markets in H2 2026

1. PMI will retain its HNB stranglehold through at least mid-2027. The iQOS Ultra supply chain readiness, TEREA production capacity in Turkey and Vietnam, and hardware upgrade rhythm set a moat that BAT’s glo platform — lacking comparable terminal inventory flexibility — cannot breach. Expect PMI SFP revenue share to stabilize between 44%-46% through FY2026.
2. BAT glo faces an extension of its valuation multiple compression. Without a Japanese-style HNB density catalyst, BAT’s dual-pillar structure will remain margin-dilutive relative to PMI. The key watch-out is Brazil and Mexico — two markets where glo could plausibly crack 8%-10% domestic HNB share by Q4 2026 if local distribution wins materialize.
3. The disposable pod segment will continue disrupting share gains from incumbents. Chinese OEM brands — represented by companies such as Shenzhen-based Vapeon Group and Guangzhou-based Eleaf International — are capturing new-switchers at sub-$5 unit price points that erode loyalty for branded pods, VUSE can competitive defensively through a rolling multi-brand portfolio strategy in 20+ SKU lines across UK , USA, Australia and EU markets.